sponsored
PatientsVille.com Logo

PatientsVille

RANITIDINE and PREVACID

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectRANITIDINEPREVACID
CHRONIC KIDNEY DISEASE1.1% 9.4%
ACUTE KIDNEY INJURY1.2% 4.4%
RENAL FAILURE1% 3.5%
NAUSEA3.4% 2.6%
DYSPNOEA3% 2.1%
DIARRHOEA2.7% 2.3%
FATIGUE2.7% 1.9%
DRUG INEFFECTIVE2.7% 1.8%
VOMITING2.5% 1.9%
HEADACHE2.5% 1.7%
END STAGE RENAL DISEASE0% 2.3%
DIZZINESS2.2% 1.7%
RENAL INJURY0% 2.2%
PAIN2.1% 1.6%
MALAISE1.9% 1.6%
PYREXIA1.7% 1.4%
ASTHENIA1.7% 1.3%
PNEUMONIA1.5% 1.2%
ARTHRALGIA1.5% 1.2%
ABDOMINAL PAIN1.4% 1.2%
FALL1.4% 1.2%
OFF LABEL USE1.4% 1.1%
RASH1.4% 1.1%
PRURITUS1.4% 0.9%
DEATH0.9% 1.4%
CHEST PAIN1.3% 1.1%
COUGH1.3% 0.9%
PAIN IN EXTREMITY1.3% 0.9%
HYPOTENSION1.3% 0.8%
TUBULOINTERSTITIAL NEPHRITIS0% 1.3%
ANXIETY1.2% 1.1%
INSOMNIA1.2% 0.9%
WEIGHT DECREASED1.2% 0.9%
BACK PAIN1.2% 0.9%
ANAEMIA1.1% 1%
DEPRESSION1.1% 1%
HYPERTENSION1.1% 0.9%
ABDOMINAL PAIN UPPER1.1% 0.9%
CONSTIPATION1.1% 0.8%
DRUG INTERACTION0.9% 1%
CONFUSIONAL STATE1% 0.9%
DECREASED APPETITE1% 0.9%
CONDITION AGGRAVATED1% 0.8%
URINARY TRACT INFECTION0.9% 0.6%
ERYTHEMA0.9% 0.5%
GASTROOESOPHAGEAL REFLUX DISEASE0.8% 0.8%
DEHYDRATION0.8% 0.8%
MUSCLE SPASMS0.8% 0.7%
OEDEMA PERIPHERAL0.7% 0.8%
SOMNOLENCE0.8% 0.7%
FEELING ABNORMAL0.8% 0.6%
TREMOR0.8% 0.6%
URTICARIA0.8% 0.5%
HYPERSENSITIVITY0.8% 0.4%
HYPERCHLORHYDRIA0% 0.8%
MYOCARDIAL INFARCTION0.7% 0.7%
MYALGIA0.7% 0.7%
SEPSIS0.7% 0.6%
DYSPEPSIA0.7% 0.6%
WEIGHT INCREASED0.7% 0.6%
PARAESTHESIA0.7% 0.6%
HAEMOGLOBIN DECREASED0.7% 0.6%
BLOOD PRESSURE INCREASED0.7% 0.5%
CHEST DISCOMFORT0.7% 0.5%
HYPERHIDROSIS0.7% 0.5%
HYPOAESTHESIA0.7% 0.5%
LOSS OF CONSCIOUSNESS0.7% 0.5%
GAIT DISTURBANCE0.7% 0.5%
FLUSHING0.7% 0%
DRUG DOSE OMISSION0.7% 0%
TACHYCARDIA0.7% 0%
ABDOMINAL DISCOMFORT0.6% 0.5%
RENAL FAILURE ACUTE0.5% 0.6%
HYPONATRAEMIA0.5% 0.6%
CEREBROVASCULAR ACCIDENT0.5% 0.6%
THROMBOCYTOPENIA0.6% 0.4%
VISION BLURRED0.6% 0.4%
NEUTROPENIA0.6% 0.4%
ALOPECIA0.6% 0%
DRUG HYPERSENSITIVITY0.6% 0%
ANAPHYLACTIC REACTION0.6% 0%
NASOPHARYNGITIS0.6% 0%
BLOOD GLUCOSE INCREASED0.5% 0.5%
GASTROINTESTINAL HAEMORRHAGE0.5% 0.5%
ATRIAL FIBRILLATION0.5% 0.5%
SYNCOPE0.5% 0.5%
PALPITATIONS0.5% 0.5%
PLATELET COUNT DECREASED0.5% 0.5%
PULMONARY EMBOLISM0.5% 0.5%
DYSPHAGIA0.5% 0.5%
RESPIRATORY FAILURE0.5% 0.4%
BLOOD CREATININE INCREASED0.5% 0.4%
ABDOMINAL DISTENSION0.5% 0.4%
CHILLS0.5% 0.4%
MUSCULAR WEAKNESS0.5% 0.4%
PRODUCT QUALITY ISSUE0.5% 0%
CARDIAC FAILURE CONGESTIVE0% 0.5%
RENAL HAEMANGIOMA0% 0.5%
REBOUND EFFECT0% 0.5%
HEART RATE INCREASED0.5% 0%
PERIPHERAL SWELLING0.5% 0%
RENAL IMPAIRMENT0% 0.5%
CONTUSION0.5% 0%
CARDIAC ARREST0.5% 0%
INJECTION SITE PAIN0.5% 0%
MEMORY IMPAIRMENT0.5% 0%
BRADYCARDIA0.5% 0%
ASTHMA0.5% 0%
DIABETES MELLITUS0% 0.4%
OVERDOSE0% 0.4%
ALANINE AMINOTRANSFERASE INCREASED0% 0.4%
ARTHRITIS0% 0.4%
WHITE BLOOD CELL COUNT DECREASED0% 0.4%
LOWER RESPIRATORY TRACT INFECTION0% 0.4%
INFECTION0% 0.4%
NEUROPATHY PERIPHERAL0% 0.4%

New treatments are found every day. View current RANITIDINE research studies and PREVACID clinical trials

1